Sinco Pharmaceuticals Holdings Limited (06833)
| Director | From | To | Position(s) | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|---|
| Huang Zhijian | 22-May-26 | Ch, ChNC | |||
| Huang Zhijian | 30-Apr-26 | AuRep | |||
| Huang Zhijian | 24-Dec-24 | V-Ch | |||
| Jing Huan | 24-Dec-24 | NED | |||
| Huang Xiangbin | 29-Mar-23 | Fdr | |||
| Jin Min | 29-Mar-23 | CEO, Non-Dir | |||
| Lei Shifeng | 29-Mar-23 | ED | |||
| Bai Zhizhong | 01-Sep-20 | INED | |||
| Peng Yunlu | 25-Oct-19 | CoSec | |||
| Lau Ying Kit | 08-Nov-18 | INED | |||
| Liu Wenfang | 01-Feb-16 | INED | |||
| Wang Qing | 01-Feb-16 | INED | |||
| Li Yifan | 02-Jun-15 | CFO | |||
| Huang Xiangbin | 29-Mar-23 | 30-Apr-26 | Ch | Mr. Huang Xiangbin has tendered his resignation to dedicate more time and attention to his other commitments. | |
| Huang Xiangbin | 30-Apr-26 | ED, AuRep | Mr. Huang Xiangbin has tendered his resignation to dedicate more time and attention to his other commitments. | ||
| Huang Zhijian | 26-Mar-24 | 24-Dec-24 | ED | ||
| Li Kin Wai | 31-Mar-21 | 26-Mar-24 | CoSec | ||
| Li Kin Wai | 26-Mar-24 | AuRep | No reasons provided | ||
| Huang Xiangbin | 16-Mar-15 | 29-Mar-23 | Ch, CEO, Fdr | ||
| Jin Min | 16-Nov-20 | 29-Mar-23 | Co-CEO | ||
| Huang Xiangbin | 29-Mar-23 | Co-CEO | Due to the need to devote more time to his other business commitment | ||
| Wong Yik Han | 22-Jan-21 | 31-Mar-21 | CoSec | ||
| Li Ching Yi | 25-Oct-19 | 22-Jan-21 | CoSec | ||
| Zhang Zhijie | 02-Jun-15 | 08-Jan-21 | ED | ||
| Ko Wing Yu | 16-Apr-15 | 25-Oct-19 | CoSec | ||
| Leung Suet Lun | 30-Aug-18 | 29-Mar-19 | CoSec | ||
| Chow Jack Siu Lui | 01-Feb-16 | 08-Nov-18 | INED | ||
| Wu Qing Jiang | 05-May-17 | 08-Nov-18 | Co-CEO | ||
| Wong Sau Ping | 30-Aug-18 | CoSec | |||
| Chen David Yu | 19-Jan-18 | 25-May-18 | INED | ||
| Wong Philip Yee Teng | 19-Jan-18 | 25-May-18 | INED | ||
| Hao Jinghui | 16-Aug-16 | 05-May-17 | Co-CEO |